Literature DB >> 21760576

Perspective: prevention is better than cure.

Sam Gandy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21760576      PMCID： PMC4052562          DOI： 10.1038/475S15a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.

Authors:  Sam Gandy
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

3.  11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

Authors:  Juha O Rinne; David J Brooks; Martin N Rossor; Nick C Fox; Roger Bullock; William E Klunk; Chester A Mathis; Kaj Blennow; Jerome Barakos; Aren A Okello; Sofia Rodriguez Martinez de Liano; Enchi Liu; Martin Koller; Keith M Gregg; Dale Schenk; Ronald Black; Michael Grundman
Journal:  Lancet Neurol       Date:  2010-02-26       Impact factor: 44.182

4.  Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.

Authors:  William D Knight; Aren A Okello; Natalie S Ryan; Federico E Turkheimer; Sofia Rodríguez Martinez de Llano; Paul Edison; Jane Douglas; Nick C Fox; David J Brooks; Martin N Rossor
Journal:  Brain       Date:  2010-11-16       Impact factor: 13.501

Review 5.  The genetics of Alzheimer disease: back to the future.

Authors:  Lars Bertram; Christina M Lill; Rudolph E Tanzi
Journal:  Neuron       Date:  2010-10-21       Impact factor: 17.173

6.  Senile dementia of the Alzheimer type.

Authors:  R D Terry; R Katzman
Journal:  Ann Neurol       Date:  1983-11       Impact factor: 10.422

7.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422
  7 in total
  16 in total

1.  Chromatin plasticity and the pathogenesis of Huntington disease.

Authors:  Michelle E Ehrlich; Sam Gandy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

Review 2.  Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

Authors:  Sam Gandy; Steven T DeKosky
Journal:  Annu Rev Med       Date:  2013       Impact factor: 13.739

3.  Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model.

Authors:  John W Steele; Hannah Brautigam; Jennifer A Short; Allison Sowa; Mengxi Shi; Aniruddha Yadav; Christina M Weaver; David Westaway; Paul E Fraser; Peter H St George-Hyslop; Sam Gandy; Patrick R Hof; Dara L Dickstein
Journal:  J Comp Neurol       Date:  2014-07-01       Impact factor: 3.215

4.  Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease.

Authors:  Patrizia Giannoni; Florence Gaven; Dimitri de Bundel; Kevin Baranger; Evelyne Marchetti-Gauthier; François S Roman; Emmanuel Valjent; Philippe Marin; Joël Bockaert; Santiago Rivera; Sylvie Claeysen
Journal:  Front Aging Neurosci       Date:  2013-12-24       Impact factor: 5.750

5.  S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.

Authors:  Md Imran Khan; Yu-Kai Su; Jinhao Zou; Lee-Wei Yang; Ruey-Hwang Chou; Chin Yu
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

6.  Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 mice.

Authors:  Neel R Nabar; Fang Yuan; Xiaoyang Lin; Li Wang; Ge Bai; Jonathan Mayl; Yaqiong Li; Shu-Feng Zhou; Jinhuan Wang; Jianfeng Cai; Chuanhai Cao
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

7.  Identification of myo-inositol hexakisphosphate (IP6) as a β-secretase 1 (BACE1) inhibitory molecule in rice grain extract and digest.

Authors:  Takako K Abe; Masayuki Taniguchi
Journal:  FEBS Open Bio       Date:  2014-01-31       Impact factor: 2.693

8.  A blood based 12-miRNA signature of Alzheimer disease patients.

Authors:  Petra Leidinger; Christina Backes; Stephanie Deutscher; Katja Schmitt; Sabine C Mueller; Karen Frese; Jan Haas; Klemens Ruprecht; Friedemann Paul; Cord Stähler; Christoph J G Lang; Benjamin Meder; Tamas Bartfai; Eckart Meese; Andreas Keller
Journal:  Genome Biol       Date:  2013-07-29       Impact factor: 13.583

9.  Voltammetric detection of S100B protein using His-tagged receptor domains for advanced glycation end products (RAGE) immobilized onto a gold electrode surface.

Authors:  Edyta Mikuła; Aleksandra Wysłouch-Cieszyńska; Liliya Zhukova; Monika Puchalska; Peter Verwilst; Wim Dehaen; Jerzy Radecki; Hanna Radecka
Journal:  Sensors (Basel)       Date:  2014-06-17       Impact factor: 3.576

10.  Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology.

Authors:  B Readhead; J-V Haure-Mirande; B Zhang; V Haroutunian; S Gandy; E E Schadt; J T Dudley; M E Ehrlich
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.